HOME > Investors > Press Releases
Subject ViroMed reports operating profit increased by 342% from previous year
Writer ViroMed
Date 2016/01/25

Change in sales or profit (KRW)

2015

2014

Change

Growth Rate (%)

Total revenue

 

7,694,840,670

6,138,023,156

1,556,817,514

25.3

Operating profit

1,090,038,690

246,462,168

843,576,522

342.2

Continuing income before income taxes

334,969,999

158,583,518

176,386,481

111.2

Net income

296,112,709

158,583,518

137,529,191

86.7

Total assets

70,693,195,706

70,368,894,648

Total liabilities

3,457,499,908

3,304,506,686

Total equity

67,235,695,798

67,064,387,962

Capital

7,098,938,500

7,098,938,500

Causes of income structure change

-        Research and license fees

Board of directors decision date

2016-01-25

Presence of superintendent

(not outside director)

None

Other considerations for investors

-        The operating statement was completed following K-IRFS standards

-        The content is for internal use only. It is subject to change due to external audit process and shareholder approval

-        Decision date is the submission date to securities & futures committees

Related disclosure

None

The information provided is still under auditing process. The information is subject to change according to the audit results.